Mass. pharmacy recalling some compounded products

March 25, 2013 by Bob Salsberg

(AP)—A Massachusetts pharmacy has issued a voluntary recall of some sterile compounding products.

Pallimed Solutions Inc., of Woburn, said Monday the recall was a precautionary measure and there were no reports of any illnesses. It says it issued the recall after a recent unannounced inspection by state and federal regulators.

A person familiar with the investigation told The Associated Press that officials are analyzing a foreign substance that was visible in several vials. The person spoke on condition of because the investigation is ongoing.

The company says the recalled products were prepared for fewer than 800 patients and the recall doesn't involve any other product.

The state stepped up inspections of compounding pharmacies after a deadly fungal was linked to a steroid produced at a different pharmacy.

shares

Related Stories

US pharmacy linked to outbreak issues wide recall

October 7, 2012

(AP)—The pharmacy that distributed a steroid linked to an outbreak of fungal meningitis has issued a voluntary recall of all of its products, calling the move a precautionary measure.

2nd firm agrees to temporary shutdown in outbreak

October 10, 2012

(AP)—A Massachusetts company run by the same executives who operated a specialty pharmacy linked to a fatal meningitis outbreak has agreed to temporarily shut down for inspection by state and federal regulators.

FDA: Ameridose issues voluntary recall of all products

November 2, 2012

(HealthDay)—Ameridose, a Massachusetts-based manufacturer of sterile injectable products and oral syringes, is undergoing a voluntary recall of all unexpired products in circulation, according to an Oct. 31 news release ...

US warns of mold in recalled specialty drugs

March 18, 2013

The U.S. Food and Drug Administration warned doctors and hospital managers Monday about a nationwide recall of all drugs made by a New Jersey compounding pharmacy because of possible mold contamination.

FDA: Georgia pharmacy recalling all sterile drugs

March 21, 2013

(AP)—The Food and Drug Administration says a Georgia compounding pharmacy that distributed a drug linked to eye infections is now recalling all of its injectable medicines following a federal inspection.

Recommended for you

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.